Supernus Pharmaceuticals Inc. (SUPN) Dropped -8.72% or -4.65 To Price $48.7 On Wednesday


Supernus Pharmaceuticals Inc. (SUPN) dropped -8.72% or -4.65 to $48.7. It is close to 2.50 million shares traded, which is 380.12% compare to the average total volume 658823. The market cap of SUPN is $2.52 billion. The year to date change is 23.18%. The 52 week price range is from $33.3 to $61.25. N/A It have changed 2.40% over last month, 18.29% over last 3 months, 40.03% over last 6 months and 26.72% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for SUPN is 54.85. It is 12.63% above current price. The 200-day Moving Averages for SUPN is 45.76. It is -6.04% below current price. The 52-week High is 61.25. It is 25.77% from the current price. The 52-week Low is 33.3. It is -31.62% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of SUPN is 8.25 on 2018-07-13. Short % to float is 13.73%. There are some statistics of SUPN. It is has market cap $2.52 billion. The share outstanding is 51.80 million. The average volume is 658823. The revenue is 156.23M. The gross profit is 148.12M. The percent of top 15 Institution holding is 97.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of SUPN is 26.29%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of SUPN is 12.78%.


Tags:

Share this post